Mach JP - Search Results

1

In vivo targeting of an anti-tumor antibody coupled to antigenic MHC class I complexes induces specific growth inhibition and regression of established syngeneic tumor grafts.

Donda A, Cesson V, Mach JP, Corradin G, Primus FJ, Robert B. Donda A, et al. Among authors: mach jp. Cancer Immun. 2003 Aug 14;3:11. Cancer Immun. 2003. PMID: 12916958

2

Peptabody-EGF: a novel apoptosis inducer targeting ErbB1 receptor overexpressing cancer cells.

Fattah OM, Cloutier SM, Kündig C, Felber LM, Gygi CM, Jichlinski P, Leisinger HJ, Gauthier ER, Mach JP, Deperthes D. Fattah OM, et al. Among authors: mach jp. Int J Cancer. 2006 Nov 15;119(10):2455-63. doi: 10.1002/ijc.21541. Int J Cancer. 2006. PMID: 16858684

3

Selection of human single chain Fv antibody fragments binding and inhibiting Helicobacter pylori urease.

Houimel M, Corthesy-Theulaz I, Fisch I, Wong C, Corthesy B, Mach J, Finnern R. Houimel M, et al. Tumour Biol. 2001 Jan-Feb;22(1):36-44. doi: 10.1159/000030153. Tumour Biol. 2001. PMID: 11054025

4

Activation of the alternative pathway of human complement by autologous cells expressing transmembrane recombinant properdin.

Vuagnat BB, Mach J, Le Doussal JM. Vuagnat BB, et al. Mol Immunol. 2000 Jun;37(8):467-78. doi: 10.1016/s0161-5890(00)00069-9. Mol Immunol. 2000. PMID: 11090881

5

CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses.

Corgnac S, Perret R, Derré L, Zhang L, Stirnemann K, Zauderer M, Speiser DE, Mach JP, Romero P, Donda A. Corgnac S, et al. Among authors: mach jp. Cancer Immunol Immunother. 2013 Apr;62(4):747-60. doi: 10.1007/s00262-012-1381-7. Epub 2012 Dec 15. Cancer Immunol Immunother. 2013. PMID: 23242316 Free PMC article.

6

Introduction to monoclonal antibodies.

Mach JP. Mach JP. Cancer Immun. 2012;12:11. Epub 2012 May 1. Cancer Immun. 2012. PMID: 22896756 Free PMC article. Review. No abstract available.

7

Highly efficient DNA incorporation of intratumourally injected [125I]iododeoxyuridine under thymidine synthesis blocking in human glioblastoma xenografts.

Buchegger F, Adamer F, Schaffland AO, Kosinski M, Grannavel C, Dupertuis YM, de Tribolet N, Mach JP, Delaloye AB. Buchegger F, et al. Among authors: mach jp. Int J Cancer. 2004 May 20;110(1):145-9. doi: 10.1002/ijc.20112. Int J Cancer. 2004. PMID: 15054880

8

CART cells are prone to Fas- and DR5-mediated cell death.

Tschumi BO, Dumauthioz N, Marti B, Zhang L, Lanitis E, Irving M, Schneider P, Mach JP, Coukos G, Romero P, Donda A. Tschumi BO, et al. Among authors: mach jp. J Immunother Cancer. 2018 Jul 13;6(1):71. doi: 10.1186/s40425-018-0385-z. J Immunother Cancer. 2018. PMID: 30005714 Free PMC article.

9

iNKT/CD1d-antitumor immunotherapy significantly increases the efficacy of therapeutic CpG/peptide-based cancer vaccine.

Corgnac S, Perret R, Zhang L, Mach JP, Romero P, Donda A. Corgnac S, et al. Among authors: mach jp. J Immunother Cancer. 2014 Nov 18;2(1):39. doi: 10.1186/s40425-014-0039-8. eCollection 2014. J Immunother Cancer. 2014. PMID: 25426294 Free PMC article.

10

Radioimmunotherapy combined with maintenance anti-CD20 antibody may trigger long-term protective T cell immunity in follicular lymphoma patients.

Buchegger F, Larson SM, Mach JP, Chalandon Y, Dietrich PY, Cairoli A, Prior JO, Romero P, Speiser DE. Buchegger F, et al. Among authors: mach jp. Clin Dev Immunol. 2013;2013:875343. doi: 10.1155/2013/875343. Epub 2013 Nov 26. Clin Dev Immunol. 2013. PMID: 24371449 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results